PubRank

E L Feldman

Author PubWeight™ 94.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 2005 2.19
2 Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol 1990 1.92
3 Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 1999 1.89
4 Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis. Neurology 2012 1.64
5 Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med 2012 1.50
6 Infection of the retina by human immunodeficiency virus type I. N Engl J Med 1987 1.50
7 Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance. Muscle Nerve 1993 1.42
8 Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology 2011 1.32
9 Diabetes regulates mitochondrial biogenesis and fission in mouse neurons. Diabetologia 2009 1.27
10 Complications: neuropathy, pathogenetic considerations. Diabetes Care 1992 1.24
11 Zebrafish models of collagen VI-related myopathies. Hum Mol Genet 2010 1.21
12 Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol 1990 1.21
13 Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-I-stimulated lamellipodial advance. J Biol Chem 1997 1.19
14 Diabetic neuropathy: scope of the syndrome. Am J Med 1999 1.19
15 A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. Diabetes Care 1997 1.17
16 Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol 1999 1.12
17 Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. J Neuropathol Exp Neurol 2001 1.12
18 Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci 2001 1.10
19 Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res 1996 1.10
20 Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J Neurobiol 1998 1.09
21 Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology 1993 1.09
22 Zebrafish MTMR14 is required for excitation-contraction coupling, developmental motor function and the regulation of autophagy. Hum Mol Genet 2010 1.07
23 Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation. J Biol Chem 1997 1.07
24 Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J Cell Physiol 1996 1.06
25 New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neurol 1999 1.05
26 Insulin-like growth factor I stimulates motility in human neuroblastoma cells. Oncogene 2001 1.04
27 GTPases and phosphatidylinositol 3-kinase are critical for insulin-like growth factor-I-mediated Schwann cell motility. J Biol Chem 2000 1.03
28 Insulin-like growth factor-I and central nervous system development. Horm Metab Res 1999 1.02
29 Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 1995 0.99
30 IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol Cell Endocrinol 2000 0.99
31 mnd2: a new mouse model of inherited motor neuron disease. Genomics 1993 0.98
32 IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma. Cell Death Differ 2000 0.97
33 Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol 1998 0.96
34 Studies on the localization of newly added membrane in growing neurites. J Neurobiol 1981 0.96
35 Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells. Apoptosis 2005 0.96
36 Differential regulation of focal adhesion kinase and mitogen-activated protein kinase tyrosine phosphorylation during insulin-like growth factor-I-mediated cytoskeletal reorganization. J Neurochem 1998 0.95
37 Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I. J Biol Chem 1998 0.95
38 Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991 0.95
39 Impaired glucose tolerance--does it cause neuropathy? Muscle Nerve 2001 0.95
40 Central nervous system endoplasmic reticulum stress in a murine model of type 2 diabetes. Diabetologia 2012 0.95
41 Insulin-like growth factor-I in muscle metabolism and myotherapies. Neurobiol Dis 2001 0.95
42 Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 1995 0.94
43 Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose. Horm Metab Res 1999 0.94
44 The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 1994 0.94
45 Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 1996 0.93
46 The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet Med 1995 0.93
47 Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells. J Neurobiol 1999 0.92
48 Autosomal dominant exudative vitreoretinopathy. Arch Ophthalmol 1983 0.92
49 Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. J Biol Chem 1998 0.92
50 Dysphagia in elderly men with myasthenia gravis. J Neurol Sci 1996 0.92
51 Caveolin-1 expression in Schwann cells. Glia 1999 0.91
52 Cofilin activity during insulin-like growth factor I-stimulated neuroblastoma cell motility. Cell Mol Life Sci 2005 0.91
53 Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells. Exp Cell Res 1995 0.90
54 Insulin-like growth factor-I and Bcl-X(L) inhibit c-jun N-terminal kinase activation and rescue Schwann cells from apoptosis. J Neurochem 2001 0.90
55 Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. J Neurochem 1996 0.90
56 Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma. Cell Death Differ 2004 0.90
57 Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat. Metabolism 1996 0.90
58 Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol 2000 0.89
59 Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). J Peripher Nerv Syst 2014 0.89
60 Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve 2005 0.88
61 Regulation of insulin-like growth factor-IL expression and its role in autocrine growth of human neuroblastoma cells. J Cell Physiol 1993 0.88
62 Gene expression of the insulin-like growth factors and their receptors in cultured human retinal pigment epithelial cells. Brain Res Mol Brain Res 1992 0.87
63 Tyrosine phosphorylation and enhanced expression of paxillin during neuronal differentiation in vitro. J Biol Chem 1996 0.87
64 Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. Diabetologia 2013 0.86
65 PTEN/MMAC1 overexpression decreases insulin-like growth factor-I-mediated protection from apoptosis in neuroblastoma cells. Cell Growth Differ 2001 0.86
66 Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression. Gene Ther 2009 0.86
67 Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Neurology 1992 0.86
68 Regulation of insulin-like growth factor-binding protein-5 expression during Schwann cell differentiation. Endocrinology 1999 0.85
69 Characterization of adenoviral gene expression in spinal cord after remote vector delivery. Neurosurgery 1999 0.84
70 Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage. Diabetes Metab Rev 1993 0.84
71 Differences between collagen morphologies, properties and distribution in diabetic and normal biobreeding and Sprague-Dawley rat sciatic nerves. J Biomech 2004 0.84
72 Gene expression of the insulin-like growth factors and their receptors in human neuroblastoma cell lines. Brain Res Mol Brain Res 1992 0.83
73 Immunohistochemical localization of insulin-like growth factor binding protein-5 in the developing rat nervous system. Brain Res Dev Brain Res 1996 0.83
74 IGF receptor function and regulation in autocrine human neuroblastoma cell growth. Regul Pept 1993 0.83
75 Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells. Neuroscience 1997 0.83
76 Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Endocrinology 1998 0.82
77 Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells. Brain Res 1997 0.81
78 Insulin-like Growth Factors as Regulators of Cell Motility Signaling Mechanisms. Trends Endocrinol Metab 2008 0.81
79 IGF-I promotes peripheral nervous system myelination. Ann N Y Acad Sci 1999 0.81
80 Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture. Proc Natl Acad Sci U S A 1993 0.80
81 Effects of serum and insulin-like growth factors on human neuroblastoma cell growth. Regul Pept 1993 0.80
82 Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells. J Neurosci Res 1993 0.80
83 Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis. J Neurol Sci 1993 0.79
84 Remote delivery of rAAV-GFP to the rat brainstem through the recurrent laryngeal nerve. Laryngoscope 2001 0.79
85 The tyrosine kinase inhibitor methyl 2,5-dihydroxycinnimate disrupts changes in the actin cytoskeleton required for neurite formation. Brain Res Mol Brain Res 1996 0.79
86 High-titer selective serum anti-beta-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy. Neurology 1993 0.78
87 Remote adenoviral gene delivery to the spinal cord: contralateral delivery and reinjection. Neurosurgery 2001 0.78
88 Granulomatous myositis, primary biliary cirrhosis, pancytopenia, and thymoma. Muscle Nerve 2000 0.78
89 Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: a comprehensive analysis of the central and peripheral nervous systems. Neuroscience 2012 0.78
90 Mononeuropathy multiplex in tryptophan-associated eosinophilia-myalgia syndrome. Neurology 1990 0.78
91 Insulin-like growth factor-I (IGF-I) and IGF binding protein-5 in Schwann cell differentiation. J Cell Physiol 1997 0.77
92 Immunohistochemical localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 during development in the rat brain. Endocrinology 1994 0.77
93 Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells. Endocrinology 1993 0.77
94 Development and characterisation of an experimental recurrent laryngeal nerve injury model for the study of viral gene therapy. J Laryngol Otol 2007 0.76
95 Histological localization of binding sites of alpha-bungarotoxin and of antibodies specific to acetylcholine receptor in goldfish optic nerve and tectum. Brain Res 1980 0.76
96 Automated difference image analysis of lamellar ruffling: effect of temperature change on human SH-SY5Y neuroblastoma cells. J Neurosci Methods 2000 0.76
97 Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis. J Neurol Sci 1997 0.75
98 Insulin-like growth factor binding protein expression in human retinal pigment epithelial cells. Ann N Y Acad Sci 1993 0.75
99 Digital fluorescein tele-angiography. Am J Ophthalmol 1987 0.75
100 Reversibility of serum removal effects on IGF-II mRNA in human neuroblastoma cells. Ann N Y Acad Sci 1993 0.75
101 Phrenic nerve involvement in Déjérine-Sottas disease: a clinicopathological case study. Pediatr Pathol 1995 0.75
102 Acute effects of adrenergic-mediated ischemia on nerve conduction in subjects with type 2 diabetes. Metabolism 1999 0.75
103 Lectin binding to neurites of goldfish retinal explants. Brain Res 1982 0.75
104 The retina as a biochemical model of central nervous system regeneration. Neurochem Int 1980 0.75
105 The natural history of a "benign" rib lesion in a patient with a demyelinating polyneuropathy and an unusual variant of POEMS syndrome. Muscle Nerve 1994 0.75
106 PKC activity and PKC-alpha mRNA content are reduced in serum-derived human neuroblastoma cells without concomitant induction of differentiation. Exp Cell Res 1993 0.75
107 The Italian multicentre study on the prevalence of distal symmetric polyneuropathy: correlation between clinical variables and nerve conduction parameters. Italian Diabetic Neuropathy Committee. Electroencephalogr Clin Neurophysiol Suppl 1999 0.75
108 Prognosis in long-term immunosuppressive treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Epidemiol 1992 0.75
109 Laser treatment of subretinal neovascularization. Int Ophthalmol Clin 1986 0.75
110 Neurophilins and the nervous system. Muscle Nerve 1999 0.75